Cargando…

Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series

BACKGROUND: During oncologic surgery, intraoperative manipulation of tumor tissue is almost unpreventable and causes a high risk of tumor cell dissemination into venous blood. A tumor cell-reducing effect of leukocyte adhesion filter systems has been shown under in vitro conditions. METHODS: In a fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oldhafer, Karl J, Stavrou, Gregor A, Donati, Marcello, Kaudel, Philipp, Frühauf, Nils R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721985/
https://www.ncbi.nlm.nih.gov/pubmed/23866965
http://dx.doi.org/10.1186/1477-7819-11-159
_version_ 1782278118075006976
author Oldhafer, Karl J
Stavrou, Gregor A
Donati, Marcello
Kaudel, Philipp
Frühauf, Nils R
author_facet Oldhafer, Karl J
Stavrou, Gregor A
Donati, Marcello
Kaudel, Philipp
Frühauf, Nils R
author_sort Oldhafer, Karl J
collection PubMed
description BACKGROUND: During oncologic surgery, intraoperative manipulation of tumor tissue is almost unpreventable and causes a high risk of tumor cell dissemination into venous blood. A tumor cell-reducing effect of leukocyte adhesion filter systems has been shown under in vitro conditions. METHODS: In a first clinical attempt, leukocyte adhesion filters were integrated into veno-venous bypass systems in four patients undergoing extended liver surgery for secondary hepatic malignancies. Practicability, handling, and safety aspects as well as potency of cell removal and clinical side effects of the filter system were analyzed. RESULTS: All patients tolerated the application of the system without problems during operative and postoperative follow-up. Immunohistochemical staining of perioperative blood samples detected cytokeratin positive (CK+) cells in three cases during the hepatic mobilization. CONCLUSIONS: Effectiveness of CK+ cell depletion and safety of the procedure was shown. The presented surgical technique represents a safe and innovative tool; however, clinical significance has to be examined in a larger patient cohort.
format Online
Article
Text
id pubmed-3721985
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37219852013-07-25 Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series Oldhafer, Karl J Stavrou, Gregor A Donati, Marcello Kaudel, Philipp Frühauf, Nils R World J Surg Oncol Research BACKGROUND: During oncologic surgery, intraoperative manipulation of tumor tissue is almost unpreventable and causes a high risk of tumor cell dissemination into venous blood. A tumor cell-reducing effect of leukocyte adhesion filter systems has been shown under in vitro conditions. METHODS: In a first clinical attempt, leukocyte adhesion filters were integrated into veno-venous bypass systems in four patients undergoing extended liver surgery for secondary hepatic malignancies. Practicability, handling, and safety aspects as well as potency of cell removal and clinical side effects of the filter system were analyzed. RESULTS: All patients tolerated the application of the system without problems during operative and postoperative follow-up. Immunohistochemical staining of perioperative blood samples detected cytokeratin positive (CK+) cells in three cases during the hepatic mobilization. CONCLUSIONS: Effectiveness of CK+ cell depletion and safety of the procedure was shown. The presented surgical technique represents a safe and innovative tool; however, clinical significance has to be examined in a larger patient cohort. BioMed Central 2013-07-17 /pmc/articles/PMC3721985/ /pubmed/23866965 http://dx.doi.org/10.1186/1477-7819-11-159 Text en Copyright ©2013 Oldhafer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Oldhafer, Karl J
Stavrou, Gregor A
Donati, Marcello
Kaudel, Philipp
Frühauf, Nils R
Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
title Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
title_full Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
title_fullStr Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
title_full_unstemmed Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
title_short Extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
title_sort extracorporeal tumor cell filtration during extended liver surgery: first clinical use of leukocyte depletion filters – a case series
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721985/
https://www.ncbi.nlm.nih.gov/pubmed/23866965
http://dx.doi.org/10.1186/1477-7819-11-159
work_keys_str_mv AT oldhaferkarlj extracorporealtumorcellfiltrationduringextendedliversurgeryfirstclinicaluseofleukocytedepletionfiltersacaseseries
AT stavrougregora extracorporealtumorcellfiltrationduringextendedliversurgeryfirstclinicaluseofleukocytedepletionfiltersacaseseries
AT donatimarcello extracorporealtumorcellfiltrationduringextendedliversurgeryfirstclinicaluseofleukocytedepletionfiltersacaseseries
AT kaudelphilipp extracorporealtumorcellfiltrationduringextendedliversurgeryfirstclinicaluseofleukocytedepletionfiltersacaseseries
AT fruhaufnilsr extracorporealtumorcellfiltrationduringextendedliversurgeryfirstclinicaluseofleukocytedepletionfiltersacaseseries